Coastal cynanchum bungei stem and leaf extract, extraction method thereof and application of extract in preparation of liver-protecting or anti-ulcerative colitis products
Patent Information
- Application Number
- CN202411007900.9
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-25
- Publication Date
- 2024-12-03
AI Technical Summary
There are few studies on the stem and leaf extracts and biological activities of Polygonum multiflorum Binhai, especially the utilization of its above-ground parts has not been effectively developed, and the therapeutic effects on ulcerative colitis and alcoholic liver have not been fully explored.
The stems and leaves of Polygonum multi-stage liquid extraction were extracted by 78-82% aqueous ethanol solution, and then extracted with solvents such as ethyl acetate and n-butanol to obtain the anti-inflammatory and free radical scavenging ability. Polygonum multiflorum stem and leaf extract, and its therapeutic effect on ulcerative colitis and alcoholic liver was verified in animal models.
Through the application of extracts, the serological liver index was significantly reduced, the lipid accumulation of hepatocytes was reduced, the liver damage was improved, the colon length was increased, the DAI score of ulcerative colitis was reduced, and good anti-inflammatory and Free radical scavenging ability, has the effect of treating alcoholic liver and improving intestinal inflammation.
Smart Images

Figure CN119055692A_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the technical field of natural product extraction and preparation and the technical field of medicines, and relates to a stem and leaf extract of Cynanchum bungei and an extraction method thereof, and application thereof in preparing a liver-protecting or anti-ulcerative colitis product. Background Art
[0002] The information disclosed in this background technology section is only intended to enhance the understanding of the overall background of the invention, and should not necessarily be regarded as an admission or any form of suggestion that the information constitutes the prior art already known to a person skilled in the art.
[0003] Cynanchum auriculatum Royle ex Wight, also known as Binhai Baishouwu, is a common Chinese herbal medicine and traditional Chinese medicine. It mainly grows in Shandong, Jiangsu, Anhui, Zhejiang, Jiangxi, Yunnan, Hunan and other places in China, usually in valleys, grasslands, streams and other areas. Binhai Baishouwu is used as a medicinal and edible plant, with the effects of nourishing the liver and kidneys, replenishing the essence and blood, strengthening the tendons and bones, and blackening the hair. In traditional Chinese medicine theory, Binhai Baishouwu has anti-tumor, anti-inflammatory, liver-protecting, and immune-enhancing effects. It can improve blood circulation, promote hair growth, and delay aging. It is often used to treat symptoms such as liver and kidney deficiency, soreness of the waist and knees, premature graying of hair, and hair loss. Because previous research on Binhai Baishouwu focused on the roots, its above-ground parts have not been effectively developed.
[0004] Ulcerative colitis (UC) is a chronic inflammatory bowel disease that primarily affects the mucosa of the colon (large intestine). The disease tends to come and go and is characterized by ulcers and inflammation on the mucosal surface. Ulcerative colitis typically affects the lining of the rectum and colon and can involve a continuous segment or the entire colon. Liver disease refers to a variety of diseases that occur in liver tissue. The liver is an important organ that performs a variety of physiological functions, including metabolism, detoxification, protein synthesis, and more. The causes of liver disease vary and can include viral infections, alcohol abuse, autoimmune diseases, fatty liver disease, drug reactions, genetic factors, and more. Some studies have shown that Cynanchum multiflorum may have antioxidant and anti-inflammatory properties, both of which have a definite impact on liver and intestinal health. Antioxidant effects help protect against damage from free radicals, while anti-inflammatory effects help reduce inflammatory responses. However, the inventors found that there are still few reports on the stem and leaf extracts of Cynanchum multiflorum and its biological activity, and the utilization of its above-ground parts is rare. Therefore, it is necessary to conduct further in-depth research on the stem and leaf extracts of Cynanchum multiflorum, so as to provide a basis for the comprehensive development and utilization of Cynanchum multiflorum. Summary of the invention
[0005] The present invention constructs a mouse alcoholic liver model by intragastric administration of 50% ethanol, and experiments have shown that the stem and leaf extract of Cynanchum bungei has the efficacy of improving alcoholic liver. Serological index analysis, staining section microscopy and other techniques have proved that the stem and leaf extract of Cynanchum bungei has the effect of reducing serological liver indicators, reducing hepatocyte lipid accumulation, and improving mouse liver damage; at the same time, the present invention extracts the stem and leaf of Cynanchum bungei with ethanol, and then uses petroleum ether, ethyl acetate, and n-butanol to prepare different extraction parts. Then it is applied to the mouse ulcerative colitis model induced by dextran sulfate sodium (DSS), and experiments have shown that the n-butanol part helps to increase the body weight of DSS colitis mice, reduce DAI scores, increase colon length, improve pathological damage, and reduce the level of pro-inflammatory factors. Based on the above research results, the present invention is completed.
[0006] The purpose of the present invention is to provide a Cynanchum bungei stem and leaf extract and an extraction method thereof and application thereof in preparing a liver protection or anti-ulcerative colitis product.
[0007] In order to achieve the above technical objectives, the technical solution adopted by the present invention is as follows:
[0008] In a first aspect, a method for extracting an extract of Cynanchum multiflorum stems and leaves is provided, wherein an ethanol aqueous solution having a volume fraction of 78 to 82% is used to reflux extract the stems and leaves of Cynanchum multiflorum to obtain an ethanol extract, the ethanol extract is concentrated and dried to obtain an ethanol extract concentrate, the ethanol extract concentrate is added with water to prepare an aqueous suspension, and then the aqueous suspension is subjected to one or more of the following extraction methods to obtain an ethyl acetate extraction portion and / or an n-butanol extraction portion, namely, the Cynanchum multiflorum stem and leaf extract;
[0009] Extraction method 1: extraction with ethyl acetate;
[0010] Extraction method 2: extraction with n-butanol;
[0011] Extraction method 3: Extraction with petroleum ether and n-butanol in sequence;
[0012] Extraction method 4: Extraction with petroleum ether and n-butanol in sequence;
[0013] Extraction method 5: Extraction with ethyl acetate and n-butanol in sequence;
[0014] Extraction method 6: Extraction was carried out using petroleum ether, ethyl acetate and n-butanol in sequence.
[0015] The present invention has found that the ethyl acetate extraction fraction and the n-butanol extraction fraction obtained by the above-mentioned extraction method have good anti-inflammatory effects and free radical scavenging abilities, wherein the n-butanol extraction fraction helps to increase the body weight of DSS colitis mice, reduce the DAI score, increase the colon length, improve pathological damage, and reduce the level of pro-inflammatory factors.
[0016] In a second aspect, a Cynomorium multiflorum stem and leaf extract is obtained by the extraction method described in the first aspect of the present invention.
[0017] In a third aspect, a use of the Cynanchum multiflorum stem and leaf extract described in the second aspect of the present invention in the preparation of anti-inflammatory and / or free radical scavenging products.
[0018] In a fourth aspect, a use of the Cynanchum multiflorum stem and leaf extract described in the second aspect of the present invention in the preparation of a liver protection and / or anti-ulcerative colitis product, wherein the Cynanchum multiflorum stem and leaf extract is the Cynanchum multiflorum stem and leaf extract of the extraction part of n-butanol.
[0019] In a fifth aspect, a method for preventing and treating alcoholic liver disease and / or improving intestinal inflammation comprises administering the Cynanchum multiflorum stem and leaf extract described in the second aspect of the present invention to a subject, wherein the Cynanchum multiflorum stem and leaf extract is the Cynanchum multiflorum stem and leaf extract of the extraction part of n-butanol.
[0020] The beneficial effects of the present invention are:
[0021] The present invention uses the stems and leaves of Cynanchum bungei as raw materials, adopts a multi-stage liquid-liquid extraction method to obtain the stem and leaf extract of Cynanchum bungei, and proves for the first time through animal experiments that the stem and leaf extract of Cynanchum bungei has the efficacy of treating alcoholic liver disease and improving intestinal inflammation, and has good health and therapeutic value. At the same time, the extraction and preparation method of the present invention is simple, easy to be converted into a modern industrial production process, and has great development potential, so it can achieve good economic and social benefits. BRIEF DESCRIPTION OF THE DRAWINGS
[0022] The accompanying drawings in the specification, which constitute a part of the present invention, are used to provide a further understanding of the present invention. The exemplary embodiments of the present invention and their descriptions are used to explain the present invention and do not constitute improper limitations on the present invention.
[0023] Figure 1 The effect of the extract of Cynanchum multiflorum stem and leaf on alcohol dehydrogenase (ADH) in the liver of mice with alcoholic liver disease in the present invention;
[0024] Figure 2 The effect of the extract of Cynanchum multiflorum stem and leaf on serum alanine aminotransferase (ALT) in mice with alcoholic liver disease in the present invention;
[0025] Figure 3 The effect of the extract of Cynanchum multiflorum stem and leaf on serum aspartate aminotransferase (AST) in mice with alcoholic liver disease in the present invention;
[0026] Figure 4 The effect of the extract of Cynanchum multiflorum stem and leaf on the protein in the liver of alcoholic liver mice in the embodiment of the present invention;
[0027] Figure 5 The effect of the extract of Cynanchum multiflorum stem and leaf on serum malondialdehyde (MDA) in mice with alcoholic liver disease in the present invention;
[0028] Figure 6 The effect of the extract of Cynanchum multiflorum stem and leaf on superoxide dismutase (SOD) in the liver of alcoholic liver mice in the embodiment of the present invention;
[0029] Figure 7 The effect of the extract of Cynanchum multiflorum stem and leaf on triglyceride (TG) in the liver of mice with alcoholic liver disease in the present invention;
[0030] Figure 8 Pathological sections of the liver of mice in each group in the embodiment of the present invention, A is the normal group, B is the model group, C is the positive drug group, D is the 50 mg / kg group, E is the 100 mg / kg group, and F is the 200 mg / kg group;
[0031] Fig. 9 The effect of the extract of Cynanchum multiflorum stem and leaf on the body weight of mice with alcoholic liver disease in the embodiment of the present invention;
[0032] Fig.10 The effects of different extraction parts of the stems and leaves of Cynanchum multiflorum on RAW264.7 cell viability and inflammatory factors in the embodiment of the present invention; wherein A is the relative cell proliferation rate, B is IFN-γ, C is IL-6, and D is IL-10;
[0033] Fig.11 is the free radical scavenging capacity of different extraction parts of the stems and leaves of Cynanchum multiflorum in the embodiment of the present invention; A is DPPH, B is ABTS;
[0034] Fig.12 The structure of the compound isolated from the ethyl acetate part of the stems and leaves of Cynanchum multiflorum in the embodiment of the present invention;
[0035] Fig.13 The results of the measurement of mouse weight, DAI, and colon length in the examples of the present invention;
[0036] Fig.14 The mouse colon tissue sections in the examples of the present invention, A is the normal group, B is the model group, C is the 50 mg / kg group, D is the 100 mg / kg group, and E is the 200 mg / kg group;
[0037] Fig.15 These are the results of the determination of mouse serum inflammatory factors in the examples of the present invention. DETAILED DESCRIPTION
[0038] It should be noted that the following detailed descriptions are exemplary and are intended to provide further explanation of the present invention. Unless otherwise specified, all technical and scientific terms used herein have the same meanings as those commonly understood by those skilled in the art to which the present invention belongs.
[0039] It should be noted that the terms used herein are only for describing specific embodiments and are not intended to limit exemplary embodiments according to the present invention. As used herein, unless the context clearly indicates otherwise, the singular form is also intended to include the plural form. In addition, it should be understood that when the terms "comprising" and / or "including" are used in this specification, it indicates the presence of features, steps, operations, devices, components and / or combinations thereof.
[0040] The invention provides a sea cucumber stem and leaf extract, an extraction method thereof and application of the extract in preparing a liver-protecting or ulcerative colitis-resistant product.
[0041] A typical embodiment of the present invention provides a method for extracting the extract of Cynanchum multiflorum stems and leaves, wherein an ethanol aqueous solution with a volume fraction of 78 to 82% is used to reflux extract the stems and leaves of Cynanchum multiflorum to obtain an ethanol extract, the ethanol extract is concentrated and dried to obtain an ethanol extract concentrate, the ethanol extract concentrate is added with water to prepare an aqueous suspension, and then the aqueous suspension is subjected to one or more of the following extraction methods to obtain an ethyl acetate extraction portion and / or an n-butanol extraction portion, namely, the extract of Cynanchum multiflorum stems and leaves;
[0042] Extraction method 1: extraction with ethyl acetate;
[0043] Extraction method 2: extraction with n-butanol;
[0044] Extraction method 3: Extraction with petroleum ether and n-butanol in sequence;
[0045] Extraction method 4: Extraction with petroleum ether and n-butanol in sequence;
[0046] Extraction method 5: Extraction with ethyl acetate and n-butanol in sequence;
[0047] Extraction method 6: Extraction was carried out using petroleum ether, ethyl acetate and n-butanol in sequence.
[0048] The reflux extraction described in the present invention refers to heating the sample system to be extracted, causing the solvent in the system to volatilize and then be cooled and flow back to the original system, and extracting the raw material in the system where the solvent repeatedly flows back.
[0049] In some embodiments, the reflux extraction time is 2 to 4 hours, and the number of reflux extractions is 2 to 4 times.
[0050] In some embodiments, the ethanol extract is filtered and then concentrated and dried to obtain an ethanol extract concentrate, thereby preventing solid residues from reducing the activity of the Cynanchum multiflorum stem and leaf extract.
[0051] In some embodiments, during the extraction, the volume ratio of the aqueous suspension to the extraction solvent is 1:0.9-1.1.
[0052] In some embodiments, during the extraction process, each extractant is extracted 3 to 7 times.
[0053] In some embodiments, the extracted liquid is concentrated under reduced pressure and dried to obtain an extracted fraction.
[0054] A second embodiment of the present invention provides a Cynomorium multiflorum stem and leaf extract obtained by the extraction method described in the first aspect of the present invention.
[0055] A third embodiment of the present invention provides a use of the Cynanchum multiflorum stem and leaf extract described in the second aspect of the present invention in the preparation of anti-inflammatory and / or free radical scavenging products.
[0056] In some embodiments, the product is a medicine or a food or a cosmetic.
[0057] The food can be understood as any edible form. For example, the food in the present invention includes ordinary food and special food. The special food in the present invention includes health food and special medical formula food. Ordinary food is relative to special food and is a food suitable for everyone.
[0058] The drug can be administered in a unit dosage form, and the dosage form can be a liquid dosage form or a solid dosage form. The liquid dosage form can be a true solution, a colloid, a microparticle dosage form, an emulsion dosage form, or a suspension dosage form. Other dosage forms include tablets, capsules, dripping pills, aerosols, pills, powders, solutions, emulsions, granules, suppositories, freeze-dried powder injections, inclusion compounds, landfills, patches, and liniments. The drug can be used for humans and non-human animals.
[0059] The fourth embodiment of the present invention provides an application of the Cynanchum multiflorum stem and leaf extract described in the second aspect of the present invention in the preparation of liver protection and / or anti-ulcerative colitis products, wherein the Cynanchum multiflorum stem and leaf extract is the Cynanchum multiflorum stem and leaf extract of the extraction part of n-butanol.
[0060] In some embodiments, the product is a medicine or a food. Specifically, the food can be a health food.
[0061] In some embodiments, the liver protection product is used to treat alcoholic liver disease. Specifically, the alcoholic liver disease is mediated by DSS.
[0062] In some embodiments, ulcerative colitis is mediated by DSS.
[0063] A fifth embodiment of the present invention provides a method for preventing and treating alcoholic liver disease and / or improving intestinal inflammation, the method comprising administering the above-mentioned Cynanchum multiflorum stem and leaf extract to a subject, wherein the Cynanchum multiflorum stem and leaf extract is the Cynanchum multiflorum stem and leaf extract of the extraction part of n-butanol.
[0064] The prevention and treatment mentioned in the present invention refers to prevention and / or treatment, wherein prevention refers to delaying, reducing, avoiding or preventing the occurrence of such disease or disease-related symptoms before the administration of relevant drugs and under the premise that no disease or disease-related symptoms occur; treatment refers to alleviating, reducing, improving or eliminating the disease or disease-related symptoms targeted by the relevant drugs after the administration of relevant drugs.
[0065] In some embodiments, the subject can be a human or a non-human animal, preferably a human.
[0066] In order to enable those skilled in the art to more clearly understand the technical solution of the present invention, the technical solution of the present invention will be described in detail below in conjunction with specific embodiments.
[0067] Example 1: Preparation of Cynanchum multiflorum stem and leaf extract
[0068] After 10 kg of the stems and leaves of Cynanchum bungei were crushed into fine powder, they were refluxed and extracted with 80% ethanol for 3 times, each time for 3 hours. After that, the obtained ethanol extract was filtered and concentrated under reduced pressure, and vacuum dried to obtain 3.9 kg of ethanol extract. The extract was added with water to make an aqueous suspension, and then extracted with petroleum ether, ethyl acetate, and n-butanol in a ratio of 1:1, and each part was extracted 3-7 times. The obtained extract was concentrated and dried under reduced pressure to obtain petroleum ether part (37.6 g), ethyl acetate part (59.8 g), and n-butanol part (145.5 g), respectively.
[0069] Among them, the chemical structure of the ethyl acetate part is as follows Fig.12 The results of UPLC-MS characterization of the n-butanol part are shown in Table 1.
[0070] Table 1 Results of UPLC-MS characterization of n-butanol fraction of Cynanchum multiflorum stems and leaves
[0071]
[0072]
[0073] The obtained extract of Cynanchum multiflorum stem and leaf was used in Examples 2-4. Example 2: Activity screening of different extraction parts of the extract of Cynanchum multiflorum stem and leaf
[0074] Experimental methods:
[0075] Determination of cell viability
[0076] 0.2 g of each extraction part in Example 1 was taken and prepared into 100 μL samples with concentrations of 1000, 500, 250, 125, and 62.5 μg / mL using DMEM culture medium. RAW264.7 cells were cultured with DMEM medium (1% double antibody, 10% fetal bovine serum) and placed in 5% CO 2 The cells were incubated in an incubator at 37°C. When the cells grew to the logarithmic growth phase, the cells were subcultured and the third generation cells were used in this experiment. RAW264.7 cells in the logarithmic growth phase were taken and the number of cells was adjusted to 5×10 5 Each well was inoculated with 10 μL of CK-8 solution and incubated in a cell culture incubator for 24 h. After that, 10 μL of CCK-8 solution was added to each well, and the absorbance (OD) was measured at 450 nm after incubation in the incubator for 2 h. Cell viability was calculated according to the following formula: Cell viability (%) = (AC) / (BC) × 100% (A represents the OD value of the drug group; B is the OD value of the normal group; C is the OD value of the blank well).
[0077] Determination of inflammatory factors
[0078] The cells treated with growth medium only were set as the normal control group, the cells treated with LPS (1 μg / mL) were set as the model group, and the cells treated with LPS (1 μg / mL) and different extraction samples (125 μg / mL) were set as the drug group. 5 Cells were seeded in 12-well plates, with 6 replicate wells in each group, and placed in a cell culture incubator for 24 h. Afterwards, the cell supernatant was collected, and the changes in the content of IFN-γ, IL-6, and IL-10 in each group were detected according to the instructions of the ELASA kit.
[0079] Free radical scavenging experiment
[0080] DPPH experiment
[0081] Take 0.05 g of petroleum ether, ethyl acetate, and n-butanol samples, dissolve them in 1 mL of 80% methanol, extract them by ultrasonic at 60°C, 300 W for 30 min, and take the supernatant after centrifugation. Make the test samples of 0.05, 0.1, 0.15, 0.2, and 0.25 mg / mL. Set up the measurement group (150 μL sample + 150 μL DPPH working solution), the control group (150 μL sample + 150 μL 80% methanol), and the blank group (150 μL 80% methanol + 150 μL DPPH working solution) in the EP tube. After fully mixing, take 200 μL and add them to the 96-well plate, and read the absorbance value A at 517 nm. According to the formula: DPPH free radical scavenging rate (%) = [(1-(A measurement-A control) / A blank) × 100]% determination.
[0082] ABTS experiment
[0083] Take 0.5 g of petroleum ether, ethyl acetate, and n-butanol samples, dissolve them in distilled water at a ratio of 1:9, centrifuge at 12000 r / min for 5 min, and take the supernatant. Use ethanol to make the test samples of 0.05, 0.1, 0.15, 0.2, and 0.25 mg / mL. Mix equal volumes of ABTS solution and oxidant to make ABTS working stock solution, which can be used after being stored at room temperature and away from light for 12-16 hours. The prepared ABTS working stock solution can be stored at room temperature and away from light for 2-3 days. Dilute the ABTS working stock solution with anhydrous ethanol as required to make ABTS working solution before use. Set up blank wells (280μL ABTS working solution + 7μL distilled water), standard wells (280μL ABTS working solution + 7μL standard), and measurement wells (280μL ABTS working solution + 7μL sample to be tested) in a 96-well plate. Read the absorbance value A at 405 nm using an ELISA reader. According to the formula: free radical scavenging rate of the sample (%) = (A blank - A measurement) / A blank × 100 measurement.
[0084] Result analysis: This example conducted RAW264.7 cell experiments on different extraction sites, including the determination of cell viability and inflammatory factors. This example also conducted DPPH and ABTS free radical scavenging experiments, which also provided a reference for the treatment of inflammation.
[0085] like Fig.10 As shown in A, the petroleum ether, ethyl acetate, and n-butanol extracts showed an inhibitory effect on the proliferation of RAW264.7 cells in a dose-dependent manner. Among them, the n-butanol fraction showed the strongest inhibitory activity, followed by the ethyl acetate fraction and the petroleum ether fraction. In addition, when the drug dose was within 125 μg / mL, it would not have a significant effect on cell proliferation.
[0086] like Fig.10As shown in B and C, compared with the normal group, the IFN-γ and IL-6 secreted by RAW264.7 cells under the induction of LPS significantly increased. Compared with the LPS group (model group), different drug administration groups can reduce the content of IFN-γ and IL-6, and show significant statistical differences. Among them, the ethyl acetate part and the n-butanol part both showed significant inhibitory effects. Although the petroleum ether part also showed certain inhibitory activity, the effect was not as obvious as the ethyl acetate and n-butanol parts. Under the intervention of LPS, compared with the normal group, the IL-10 content secreted by the model group cells decreased slightly. Compared with the LPS group, the intervention of different drugs can increase the IL-10 content secreted by RAW264.7 cells, and they are all higher than the normal group. Among them, the ethyl acetate part is slightly higher than the n-butanol part, and they are all more effective than the petroleum ether part. Fig.10 As shown in D.
[0087] DPPH( Fig.11 ) and ABTS( Fig.11 ) The test results show that different extractions all show a certain free radical scavenging ability, and it is dose-dependent. Among them, with the continuous increase in concentration, the n-butanol part and the ethyl acetate part show a trend of approaching each other, and the scavenging ability of the n-butanol part is more significant than that of the ethyl acetate part. Overall, the scavenging rate of the petroleum ether part is lower than that of the n-butanol and ethyl acetate parts.
[0088] In summary, this example found that the n-butanol fraction and the ethyl acetate fraction had good anti-inflammatory effects and free radical scavenging abilities. Therefore, subsequent experiments were conducted on these two extraction fractions.
[0089] Example 3: The extract of Cynanchum multiflorum stems and leaves improves ethanol-induced liver damage in mice.
[0090] Experimental methods: 36 C57 male mice weighing 18-22 g were divided into 6 groups, 6 mice in each group. The drug-treated group (50, 100, 200 mg / kg were intragastrically administered with 0.2 mL of 50% ethanol (14 mL kg- 1 )), model group (0.2 mL sterile water was gavaged in the first 15 days, and 0.2 mL 50% ethanol was gavaged in the 16th day), positive drug group (0.2 mL silymarin 40 mg / kg was gavaged in the first 15 days, and 0.2 mL 50% ethanol was gavaged in the 16th day), and normal control group (0.2 mL sterile water was gavaged continuously for 16 days).
[0091] At the end of the experiment, all mice were fasted but not watered for 16 h, weighed, and blood was collected by removing the eyeballs. Serum was obtained by centrifugation at 3000 g for 10 min and stored at -80°C for biochemical index detection.
[0092] The TG, ALT, AST, and MDA levels of mouse serum were tested; the liver tissue was made into 10% tissue homogenate, and the supernatant was taken after centrifugation for protein quantification, as well as the detection of ADH content and SOD activity. The mouse liver tissue was fixed in paraformaldehyde for 48 h, then embedded in paraffin, sliced, and stained with HE to observe the pathological changes of liver tissue.
[0093] Animal model: The mice were gavaged with 0.2 mL of sterile water for the first 15 days and 0.2 mL of 50% ethanol on the 16th day.
[0094] Results analysis: In this example, ethanol was used to induce liver damage in mice to evaluate the regulatory effect of the stem and leaf extract of Cynanchum multiflorum on liver damage. The detection of TG, ALT, AST, and MDA levels in mouse serum showed that the stem and leaf extract of Cynanchum multiflorum could significantly reduce the levels of TG, ALT, AST, and MDA in mouse serum compared with the model group. Figure 2 , 3 , 5, 7; The quantitative analysis of the protein in the liver tissue of mice, as well as the detection of ADH content and SOD activity showed that the extract of Cynanchum multiflorum stem and leaf could significantly increase the ADH content in the liver tissue of mice compared with the model group, and reduce the SOD content, but had no significant effect on the protein, as shown in Figure 1 , 4 , 6; by testing the weight of each group of mice, it was found that compared with the model group, the extract of Cynanchum multiflorum stems and leaves can maintain the weight of mice within the normal range without change and is significantly different from the model group, such as Fig. 9 As shown in the figure, by observing the H&E sections of the liver tissues of mice in each group, it can be seen that the liver lobules of the extract of Cynanchum multiflorum stems and leaves were arranged more neatly than those of the model group, and the structural abnormalities and damage were reduced. The abnormal nuclear morphology was reduced, and the infiltration of inflammatory cells was reduced, such as Figure 8 shown.
[0095] These results indicate that the extract of Cynanchum multiflorum stem and leaf can reduce serum liver indexes, reduce hepatocyte lipid accumulation, and improve liver damage in mice fed with ethanol.
[0096] Example 4: The extract of Cynanchum multiflorum stems and leaves improves DSS-induced ulcerative colitis in mice
[0097] Experimental methods: 30 C57BL / 6 male mice were adaptively fed for 7 days and divided into 5 groups, with 6 mice in each group, including normal control group, model group, and drug-treated group (DSS + n-butanol part of stems and leaves of P. marinum 50, 100, 200 mg / kg). In the first 21 days, the control group and the model group were both fed with 0.2 mL of sterile water, and the drug-treated group was fed with 0.2 mL of n-butanol extract of different doses, and the mice were weighed regularly. From the 22nd day, except for the mice in the normal control group who freely drank sterile water every day, the model group and the drug-treated group freely drank 2.5% w / v DSS solution, and the DSS solution was replaced every other day. The body weight was weighed and recorded at the same time every day for 7 days. All mice were fed with ordinary feed, the feeding temperature was controlled at 20±2℃, the humidity was 50-60%, the circadian rhythm lighting was used, the bedding and feed were replaced in time, and the mice were free to eat and drink water.
[0098] DAI score: During the modeling and feeding period, the mental state and hair condition of the mice were regularly observed, and the changes in the weight, water intake, food intake, and blood in the stool were recorded. DAI scores were performed on each experimental mouse according to the scoring criteria. DAI = (weight loss score + stool shape score + blood in the stool score) / 3, as shown in Table 2.
[0099] Table 2 DAI scoring criteria
[0100]
[0101] Animal treatment and colon length determination: After modeling, the mice in each group were eyeballed and blood was collected, and then killed by dislocation. The abdominal cavity was opened and the colon was removed. Samples were taken from each group in turn, and the colon length was measured on ice.
[0102] Pathological observation: Fresh colon tissue was fixed in 4% paraformaldehyde for 24 h, and then dehydrated with alcohol, xylene, and paraffin in turn. The dehydrated colon tissue was removed and placed in an embedding frame containing melted wax, and then frozen and solidified at -20°C before removal. The wax block was placed in a slicer and processed into 4μm slices, placed in a spreader to flatten the tissue, baked at 60°C, and stored at room temperature for later use. The prepared slices were placed in xylene and alcohol in turn, and then rinsed with deionized water. After that, the slices were placed in hematoxylin stain for 3-5 min, washed with water, and then differentiated with 1% hydrochloric acid alcohol for a few seconds. After that, 0.6% ammonia water was used to turn blue, rinsed with running water, and then stained in eosin solution for 5 min. Finally, after washing with alcohol and xylene, the slices were sealed with neutral gum, and the tissues were observed under a microscope and analyzed and photographed.
[0103] Determination of inflammatory factors: The eyeball blood of each group of mice was centrifuged at 4000 r / min for 20 min, and the obtained serum was measured according to the instructions of the kit.
[0104] Animal model: Adaptive feeding for 7 days, 0.2 mL of sterile water was administered, and the mice were weighed regularly. From the 22nd day, 2.5% w / v DSS solution was freely available, and the DSS solution was changed every other day. The body weight was weighed and recorded at the same time every day for 7 days.
[0105] Result analysis:
[0106] Fig.13 A and B in the figure show the changes in mouse body weight and DAI score within 7 days of modeling, respectively. Fig.13 A in the figure shows that the body weight of mice in the model group was significantly lower than that in the normal group. When given different doses of the drug, the body weight of the mice increased compared with the model group and showed a dose-dependency, but overall the body weight of the drug-treated group was lower than that of the normal group. Fig.13 A in Figure 3 shows that the DAI score in the model group was lower than that in the normal group, while the DAI score in the drug group was higher than that in the model group as a whole. Fig.13 Figure C shows that the colon length of mice in the model group was significantly lower than that in the normal group. After different doses of drug intervention, the colon length showed an increasing trend compared with the model group, and was dose-dependent, but overall the colon length of mice in the drug group was lower than that in the normal group.
[0107] Results of pathological observation
[0108] In the normal group, the intestinal mucosal epithelium of the mice was intact, the epithelial cells were in good condition, the crypt structure was intact and arranged in order, and there was no obvious lesion in the submucosal layer. The intestinal mucosal epithelium of the mice in the model group was defective, the epithelial cells were loosely connected, the crypt structure was destroyed and arranged in disorder, a large number of inflammatory cells were infiltrated in the interstitial layer, and the submucosal layer was congested and edematous to varying degrees. With the continuous increase in the dosage, the colon tissue pathological morphology of the mice in the drug group was improved compared with the control group, the mucosal defects were significantly repaired compared with the model group, the epithelial cells were tightly connected, the goblet cells secreted more, there was very little crypt destruction, and the inflammatory cell infiltration was reduced to varying degrees, such as Fig.14 shown.
[0109] Results of inflammatory factor assays
[0110] like Fig.15 As shown in the figure, compared with the normal group, the IL-1β, IL-6, and TNF-α contents in the model group were higher than those in the normal group. When different doses of drugs were given, the IL-1β, IL-6, and TNF-α contents in the drug-treated group were lower than those in the model group, and showed a dose-dependent manner.
[0111] Based on the above research results, the present invention found that the n-butanol fraction of the stems and leaves of Cynomorium multiflorum has a good preventive effect on DSS-induced ulcerative colitis.
[0112] The above description is only a preferred embodiment of the present invention and is not intended to limit the present invention. For those skilled in the art, the present invention may have various modifications and variations. Any modification, equivalent replacement, improvement, etc. made within the spirit and principle of the present invention shall be included in the protection scope of the present invention.
Claims
1. A method for extracting a Cynomorium multiflorum stem and leaf extract, characterized in that: The invention relates to a method for extracting the stems and leaves of Cynanchum multiflorum by refluxing with an ethanol aqueous solution having a volume fraction of 78 to 82% to obtain an ethanol extract, concentrating and drying the ethanol extract to obtain an ethanol extract concentrate, adding water to the ethanol extract concentrate to prepare an aqueous suspension, and then extracting the aqueous suspension by one or more of the following extraction methods to obtain an ethyl acetate extraction part and / or an n-butanol extraction part, namely, a Cynanchum multiflorum stem and leaf extract; Extraction method 1: extraction with ethyl acetate; Extraction method 2: extraction with n-butanol; Extraction method 3: Extraction with petroleum ether and n-butanol in sequence; Extraction method 4: Extraction with petroleum ether and n-butanol in sequence; Extraction method 5: Extraction with ethyl acetate and n-butanol in sequence; Extraction method 6: Extraction was carried out using petroleum ether, ethyl acetate and n-butanol in sequence.
2. The method for extracting the Cynomorium multiflorum stem and leaf extract as claimed in claim 1, wherein: The reflux extraction time is 2 to 4 hours, and the number of reflux extractions is 2 to 4 times.
3. The method for extracting the Cynomorium multiflorum stem and leaf extract as claimed in claim 1, characterized in that: After the ethanol extract is filtered, it is concentrated and dried in sequence to obtain an ethanol extract concentrate.
4. The method for extracting the Cynomorium multiflorum stem and leaf extract as claimed in claim 1, wherein: In the extraction, the volume ratio of the aqueous suspension to the extraction solvent is 1:0.9-1.1; Alternatively, during the extraction process, each extractant is extracted 3 to 7 times.
5. The method for extracting the Cynomorium multiflorum stem and leaf extract as claimed in claim 1, characterized in that: The extracted liquid is concentrated under reduced pressure and dried to obtain the extracted part.
6. A sea cucumber stem and leaf extract, characterized in that: Obtained by the extraction method according to any one of claims 1 to 5.
7. Use of the Cynanchum multiflorum stem and leaf extract according to claim 6 in the preparation of anti-inflammatory and / or free radical scavenging products.
8. The use according to claim 7, characterized in that: The product is a medicine, a food or a cosmetic.
9. Use of the extract of Cynanchum multiflorum stems and leaves according to claim 6 in the preparation of a liver protection and / or anti-ulcerative colitis product, wherein the extract of Cynanchum multiflorum stems and leaves is the extract of Cynanchum multiflorum stems and leaves extracted with n-butanol.
10. The use according to claim 9, characterized in that: The product is a medicine or a food; Alternatively, the liver protection product is used to treat alcoholic liver disease; preferably, the alcoholic liver disease is mediated by DSS. Alternatively, ulcerative colitis is mediated by DSS.
Citation Information
Patent Citations
Composition used for preventing and treating alcoholic liver injury and having hangover alleviating effect
CN109620906A
Application of cynanchum auriculatum in preparation of product for promoting proliferation of intestinal beneficial bacteria
CN114224927A
